BridgeBio Pharma Inc (BBIO)
27.83
+0.09
(+0.32%)
USD |
NASDAQ |
May 03, 16:00
27.82
-0.01
(-0.04%)
After-Hours: 20:00
BridgeBio Pharma Profit Margin (Quarterly): -16.68% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -16.68% |
| December 31, 2023 | -9.64K% |
| September 30, 2023 | -4.33K% |
| June 30, 2023 | -9.62K% |
| March 31, 2023 | -7.68K% |
| December 31, 2022 | -7.36K% |
| September 30, 2022 | -40.63K% |
| June 30, 2022 | -13.36% |
| March 31, 2022 | -11.59K% |
| December 31, 2021 | -1.14K% |
| Date | Value |
|---|---|
| September 30, 2021 | -6.65K% |
| June 30, 2021 | -178.3% |
| March 31, 2021 | -35.30K% |
| December 31, 2020 | -98.35K% |
| September 30, 2020 | -1.43K% |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -531.6% |
| September 30, 2019 | -224.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-98.35K%
Minimum
Dec 2020
-13.36%
Maximum
Jun 2022
-13.80K%
Average
-6.65K%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 20.94% |
| Alnylam Pharmaceuticals Inc | -13.34% |
| Tandem Diabetes Care Inc | -15.25% |
| Regenxbio Inc | -283.1% |
| IDEAYA Biosciences Inc | -865.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -84.63% |
| Return on Invested Capital | -109.4% |
| Gross Profit Margin (Quarterly) | 99.72% |
| Operating Margin (Quarterly) | 1.77% |
| Return on Net Operating Assets | -533.6% |